Literature DB >> 12487373

Estrogen-induced regulation of the ATP-binding cassette transporter A1 (ABCA1) in mice: a possible mechanism of atheroprotection by estrogen.

Rai Ajit K Srivastava1.   

Abstract

Estrogens are suggested to be antiatherogenic by affecting the vessel wall components. Since ABCA1 was recently shown to be atheroprotective, it was examined if estrogen-induced atheroprotection occurs partly via the regulation of the ABCA1. Since hepatic ABCA1 expression was also suggested to contribute to the bulk HDL levels, regulation of the ABCA1 under conditions of high or low levels of HDL were investigated in mice expressing normal or elevated levels of apoAI. To delineate whether estrogen's effect occurs via estrogen receptor-alpha-mediated pathway, the estrogen receptor-alpha-deficient (ER-alpha)-/- mice were also administered either placebo or beta-estradiol for 5 consecutive days. Estrogen treatments decreased circulating HDL levels by 30%, but increased hepatic and intestinal ABCA1 mRNA by 2- and 1.5-fold, respectively. Hepatic ABCA1 mRNA also increased in the ER-alpha-/- mice by 3-fold. These results suggest that estrogen, despite lowering the levels of HDL, it up-regulated the hepatic ABCA1 mRNA, and in the absence of ER-alpha, ER-beta could compensate for ER-alpha. To study whether HDL levels correlate with the ABCA1 expression, wild-type (WT) and the apoAI transgenic (A1-Tg) mice were fed high fat (HF) diet with or without cholic acid (CA) for 3 weeks. One group of mice was treated with fenofibrate, known to elevate HDL levels. CA without HF decreased HDL levels, while fenofibrate increased HDL levels. However, neither CA nor fenofibrate altered hepatic ABCA1 mRNA levels. HF diet increased the hepatic ABCA1 mRNA 1.8-fold in WT, but lowered ABCA1 mRNA by 2-fold in A1-Tg mice, suggesting that ABCA1 levels did not correlate with circulating HDL levels, while basal levels of HDL influenced ABCA1 expression. These data show for the first time that estrogen's antiatherogenic effects may occur via ABCA1-mediated pathway, and circulating HDL levels may influence expression of ABCA1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12487373     DOI: 10.1023/a:1020604610873

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  34 in total

1.  The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease.

Authors:  M Bodzioch; E Orsó; J Klucken; T Langmann; A Böttcher; W Diederich; W Drobnik; S Barlage; C Büchler; M Porsch-Ozcürümez; W E Kaminski; H W Hahmann; K Oette; G Rothe; C Aslanidis; K J Lackner; G Schmitz
Journal:  Nat Genet       Date:  1999-08       Impact factor: 38.330

2.  Protection against atherosclerosis by estrogen is independent of plasma cholesterol levels in LDL receptor-deficient mice.

Authors:  M M Marsh; V R Walker; L K Curtiss; C L Banka
Journal:  J Lipid Res       Date:  1999-05       Impact factor: 5.922

3.  Regulation and activity of the human ABCA1 gene in transgenic mice.

Authors:  L B Cavelier; Y Qiu; J K Bielicki; V Afzal; J F Cheng; E M Rubin
Journal:  J Biol Chem       Date:  2001-03-13       Impact factor: 5.157

4.  Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice.

Authors:  E Orsó; C Broccardo; W E Kaminski; A Böttcher; G Liebisch; W Drobnik; A Götz; O Chambenoit; W Diederich; T Langmann; T Spruss; M F Luciani; G Rothe; K J Lackner; G Chimini; G Schmitz
Journal:  Nat Genet       Date:  2000-02       Impact factor: 38.330

5.  Cloning of a novel receptor expressed in rat prostate and ovary.

Authors:  G G Kuiper; E Enmark; M Pelto-Huikko; S Nilsson; J A Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

6.  Plasma HDL levels are regulated by the catabolic rate of large particles of lipoprotein containing apo-A-I.

Authors:  K Saku; R Liu; T Ohta; S Jimi; I Matsuda; K Arakawa
Journal:  Biochem Biophys Res Commun       Date:  1994-04-15       Impact factor: 3.575

Review 7.  Quantification of absolute amounts of cellular messenger RNA by RNA-excess solution hybridization.

Authors:  R A Srivastava; G Schonfeld
Journal:  Methods Mol Biol       Date:  1994

8.  Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels.

Authors:  M Haghpassand; P A Bourassa; O L Francone; R J Aiello
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

9.  Estrogen increases hepatic lipase levels in inbred strains of mice: a possible mechanism for estrogen-dependent lowering of high density lipoprotein.

Authors:  N Srivastava; P R Chowdhury; M Averna; R A Srivastava
Journal:  Mol Cell Biochem       Date:  2001-04       Impact factor: 3.396

10.  Expression of low density lipoprotein receptor, apolipoprotein AI, AII and AIV in various rat organs utilizing an efficient and rapid method for RNA isolation.

Authors:  R A Srivastava; N Srivastava; G Schonfeld
Journal:  Biochem Int       Date:  1992-06
View more
  11 in total

1.  Estrogen receptor-alpha mediates gender differences in atherosclerosis induced by HIV protease inhibitors.

Authors:  Kimberly F Allred; Eric J Smart; Melinda E Wilson
Journal:  J Biol Chem       Date:  2005-11-18       Impact factor: 5.157

Review 2.  Sex differences in vascular physiology and pathophysiology: estrogen and androgen signaling in health and disease.

Authors:  Austin C Boese; Seong C Kim; Ke-Jie Yin; Jean-Pyo Lee; Milton H Hamblin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-06-16       Impact factor: 4.733

3.  Role of the estrogen and progestin in hormonal replacement therapy on apolipoprotein A-I kinetics in postmenopausal women.

Authors:  Stefania Lamon-Fava; Borbala Postfai; Margaret Diffenderfer; Carl DeLuca; John O'Connor; Francine K Welty; Gregory G Dolnikowski; P Hugh R Barrett; Ernst J Schaefer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-12-08       Impact factor: 8.311

Review 4.  ABCA1, from pathology to membrane function.

Authors:  Ana Zarubica; Doriane Trompier; Giovanna Chimini
Journal:  Pflugers Arch       Date:  2006-07-21       Impact factor: 3.657

Review 5.  Age, APOE and sex: Triad of risk of Alzheimer's disease.

Authors:  Brandalyn C Riedel; Paul M Thompson; Roberta Diaz Brinton
Journal:  J Steroid Biochem Mol Biol       Date:  2016-03-08       Impact factor: 4.292

6.  Anti-hyperlipidemic and insulin sensitizing activities of fenofibrate reduces aortic lipid deposition in hyperlipidemic Golden Syrian hamster.

Authors:  Rai Ajit K Srivastava; Shirley He
Journal:  Mol Cell Biochem       Date:  2010-08-27       Impact factor: 3.396

7.  Genome-wide DNA methylation of the liver reveals delayed effects of early-life exposure to 17-α-ethinylestradiol in the self-fertilizing mangrove rivulus.

Authors:  Anne-Sophie Voisin; Victoria Suarez Ulloa; Peter Stockwell; Aniruddha Chatterjee; Frédéric Silvestre
Journal:  Epigenetics       Date:  2021-05-05       Impact factor: 4.861

8.  Effects of R219K polymorphism of ATP-binding cassette transporter 1 gene on serum lipids ratios induced by a high-carbohydrate and low-fat diet in healthy youth.

Authors:  Hui Liu; Jia Lin; Xing Zhu; Yuan Li; Mei Fan; Rong Zhang; Ding Fang
Journal:  Biol Res       Date:  2014-03-26       Impact factor: 5.612

9.  The ABCA1 gene R230C variant is associated with decreased risk of premature coronary artery disease: the genetics of atherosclerotic disease (GEA) study.

Authors:  Teresa Villarreal-Molina; Carlos Posadas-Romero; Sandra Romero-Hidalgo; Erika Antúnez-Argüelles; Araceli Bautista-Grande; Gilberto Vargas-Alarcón; Eric Kimura-Hayama; Samuel Canizales-Quinteros; Juan Gabriel Juárez-Rojas; Rosalinda Posadas-Sánchez; Guillermo Cardoso-Saldaña; Aída Medina-Urrutia; María Del Carmen González-Salazar; Rocío Martínez-Alvarado; Esteban Jorge-Galarza; Alessandra Carnevale
Journal:  PLoS One       Date:  2012-11-09       Impact factor: 3.240

Review 10.  Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences.

Authors:  Michelle M Mielke; Prashanthi Vemuri; Walter A Rocca
Journal:  Clin Epidemiol       Date:  2014-01-08       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.